Notice of Results
hVIVO plc has announced that its final results for the year ended 31 December 2025 will be released on Wednesday, 15 April 2026, with an analyst briefing scheduled for the same day at 11:00 AM BST. The Chief Executive Officer and Chief Financial Officer will also present the results via the Investor Meet Company platform at 6:00 PM BST on 15 April 2026, allowing for investor questions to be submitted beforehand.
Select text to share a quote on X · sign in to keep highlights & notes in your HVO notes
London, UK - 7 April 2026, hVIVO plc (AIM: HVO), a full-service early phase Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, announces that it will release its final results for the year ended 31 December 2025 on Wednesday 15 April 2026.
Analyst briefing
A briefing open to equity research analysts will take place on Wednesday 15 April 2026 at 11.00am BST. To register and for more details please contact hVIVO@icrhealthcare.com.
Investor presentation
Yamin 'Mo' Khan, Chief Executive Officer, and Stephen Pinkerton, Chief Financial Officer, will provide a live presentation relating to the final results via the Investor Meet Company platform on Wednesday 15 April 2026 at 6.00pm BST.
| Peel Hunt LLP (Joint Broker) | +44 (0)20 7418 8900 |
| James Steel, Dr Christopher Golden | |
| Davy (Joint Broker) | +353 (0) 1 679 6363 |
Anthony Farrell, Niall Gilchrist
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.